Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,121
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
for
Alzheimer's Disease
Location: Toronto, North York, London, Ottawa, Columbus OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT07094516
Phase 2, Recruiting
Semaglutide and Vascular Regeneration
for
Atherosclerosis, Cardiovascular Diseases,
Location: North York, Scarborough
Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group
Sex: All
Age: 18+
Code: NCT05870462
Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
for
Metastatic Digestive System Neuroendocrine Tumor G1,
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Toronto, East Syracuse NY, Pittsburgh PA, Lansing MI,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
MDS-CAN: A Prospective National MDS Clinical Database and Local Tissue Bank
for
Myelodysplastic Syndrome (MDS)
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 19+
Code: NCT02537990
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Toronto, Ajax, Stoney Creek, Guelph, Waterloo,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Niagara Falls, Buffalo NY, Windsor, Detroit MI,